(Hypertension. 1999;33:1359-1363.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Institute of Physiology, Humboldt University (Charité), Berlin, Germany (H.M.S., R.M., P.B.P.), and the Institute of Cardiovascular Physiology, Heinrich Heine University, Düsseldorf, Germany (A.G., J.S.).
Correspondence to Harald M. Stauss, MD, Department of Physiology, Humboldt University Berlin-Charité, Tucholskystrasse 2, 10117 Berlin, Germany. E-mail harald.stauss{at}rz.hu-berlin.de
| Abstract |
|---|
|
|
|---|
Key Words: hypertension, arterial blood pressure spectrum analysis endothelium nitric oxide
| Introduction |
|---|
|
|
|---|
The efferent arch of this blood pressure buffer depends on NO, which causes vasodilation in response to a blood pressure increase. However, it remains unknown by which pathway the initial blood pressure increase is detected. Theoretically, at least 2 mechanisms can be postulated. First, the same mechanoreceptors that are involved in the classic baroreceptor reflex may detect pressure changes and signal this information to the central nervous system. There, a neuronal pathway may be initiated that activates the neuronal isoform of NO synthase (nNOS) that subsequently causes NO production. Second, a local vascular pathway may be possible. In this local vascular pathway, changes in arterial blood pressure lead to changes in vascular shear stress. This mechanical stimulus would increase the cytosolic Ca2+ content in the endothelial cells, which in turn would activate the endothelial isoform of NO synthase (eNOS).9 10 11 12 13 The subsequently formed NO reaches the adjacent vascular smooth muscle cells, where it modulates vascular resistance to maintain blood pressure at its initial level. Because all isoforms of NO synthase have been blocked by NG-nitro-L-arginine in the former studies,7 8 it remained unclear whether the blood pressurebuffering effect of NO is mediated by NO that is formed by the eNOS or nNOS isoforms.
The purpose of the present study, therefore, was 2-fold. First, with the use of knockout mice in which the eNOS isoform was specifically mutated,14 15 we investigated whether NO that is generated by the endothelial isoform of NO synthase is involved in the blood pressurebuffering effect of NO. Second, with the use of power spectral analysis, we determined the frequency range in which endothelium-derived NO can buffer blood pressure variability in mice. As an experimental approach, spontaneous blood pressure fluctuations were compared in 13 wild-type and 10 eNOS mutant mice. To eliminate artifacts of anesthesia, experiments were performed in conscious animals, at least 24 hours after implantation of a carotid artery catheter. The animals were not restrained to avoid psychological stress, which has a large impact on blood pressure variations.16
| Methods |
|---|
|
|
|---|
Catheter Implantation and Blood Pressure Recording
For catheter implantation, the mice were anesthetized by
a single intraperitoneal dose of 4 mg/10 g body wt
chloral hydrate. The common carotid artery was exposed by a midline
incision in the anterior neck region and subsequently cannulated with a
polyethylene catheter (Portex). The catheter was shaped to fit into the
neck vicinity and the tip was tapered on a length of 5 mm to ease
cannulation of the artery. The inner diameter of the nontapered portion
of the catheter was 0.4 mm and the outer diameter was 0.8 mm.
This size of the catheter ensured a sufficiently high conductance, as
indicated by blood pressure amplitudes >30 mm Hg
(Table). Finally, the line was
exteriorized at the dorsum of the neck through subcutaneous
tunneling.
|
All experiments were performed in conscious mice at least 24 hours after implantation of a carotid artery catheter. During the experimental protocol, the animals were not restrained and could move freely in the same cages where they were housed after surgery. For blood pressure recordings, the carotid artery catheter was attached to an external line. This external line was brought straight out of the cage and guided around a metal bar that was placed 300 mm horizontally above the cage. Thus tethering of the mice was not necessary and psychological stress, which has a large impact on blood pressure variations,16 was minimized. The external line was attached to a pressure transducer (DTX Plus, Ohmeda Inc) that was located at the same level as the mouse. Finally, the pressure transducer was connected to a pressure processor amplifier (Gould 4600 Series, Gould Instrument Systems Inc) that provided the analog blood pressure signal that was digitized with a computer based monitoring system (XmAD, ftp://sunsite.unc.edu/pub/Linux/science/lab) with a sampling rate of 1000 s-1 (Hz). During the recordings, mice were continuously observed and only episodes of physical rest were saved for further analyzes. Thus >60 minutes and occasionally >120 minutes had to be allowed before a stationary blood pressure signal was monitored. During these resting conditions heart rate was consistently <600 bpm (Table).
Data Analysis and Statistics
All blood pressure time series were visually inspected on the
computer screen, and 66-second-long stationary segments were
selected (Figure 1a) with the use
of a freely available analyzing soft-ware (XmANA,
ftp://sunsite.unc.edu/pub/Linux/science/lab). Power spectra of these
segments were calculated by the fast Fourier transform, based on
65 536 values (Figure 1c). Mean blood pressure variances
(Table) were determined as the total power of the
arterial blood pressure power spectra up to a frequency of
5.0 s-1 (Hz) that was far below the heart rate
peak in all cases. Probability distributions of the mean blood pressure
values were calculated and are presented in Figure 1b.
First, mean blood pressure time series were generated by low-pass
filtering the pulsatile blood pressure signals [corner frequency 5.0
s-1 (Hz)]. Then, frequency distributions were
calculated for all 23 mean blood pressure time series by use of a
bin-width of 1.0 mm Hg. Next, the frequency distributions were
shifted on the blood pressure axis (x-axis) to the mean
blood pressure value of the respective strain and the frequency
distributions of all animals from each group were averaged. Finally,
the probability distributions were obtained by dividing the frequency
distributions by the number of data points in the mean blood pressure
time series (n=65 536). Because blood pressure variability may be
affected by the chronic increase in arterial blood pressure
in eNOS knockout mice, the correlation between mean
arterial blood pressure and mean blood pressure variance
was calculated for both strains of mice.
|
Because an enhanced blood pressure variability in eNOS knockout mice may be partly compensated for by the baroreceptor reflex, we calculated baroreceptor reflex sensitivity in both strains of mice by use of the sequence method that was first introduced by Bertinieri et al.17 This method is based on detecting spontaneously occurring sequences of 3 or more consecutive heartbeats during which both arterial blood pressure and interbeat interval simultaneously increased or decreased. These sequences were detected by use of the same algorithm as described previously.18 From each of these sequences, linear regressions were calculated for the blood pressure versus interbeat interval relation. Only sequences with a correlation coefficient (r) of >0.85 were included in the analysis. The regression coefficient or slope of the linear relation between blood pressure and interbeat interval was used as a measure for baroreceptorheart rate reflex sensitivity. If the baroreceptor reflex partly compensates an enhanced blood pressure variability in eNOS knockout mice, one would expect to find more spontaneously occurring sequences in eNOS mutant animals than in wild-type mice. Therefore the number of sequences per 1000 heart beats was calculated and used as an index for the activity of the baroreceptor reflex.
All data are expressed as mean±SEM. Statistical comparisons between eNOS knockout mice and wild-type mice were performed by unpaired t tests.
| Results |
|---|
|
|
|---|
Effects of eNOS Knockout on Blood Pressure Variability
Blood pressure variability is graphically illustrated by the
probability distribution of the mean blood pressure time series in
Figure 1b. The probability distribution in the eNOS knockout
mice is characterized by a broader distribution of the blood pressure
values (width=15 mm Hg) than the probability distribution in the
control mice (width=10 mm Hg). In addition, blood pressure variability
was expressed as the total power in the blood pressure power spectra at
frequencies below the heart rate [<5.0 s-1
(Hz)], for example, the variance of the mean blood pressure time
series. Mean blood pressure variance was significantly larger in eNOS
mutant animals than in wild-type controls (Table), which
indicates the lack of a physiologically
important blood pressure buffer. To investigate a possible role of the
chronically increased blood pressure level in eNOS mutant animals on
blood pressure variability, the correlation between mean blood pressure
and blood pressure variance was calculated. Figure 2 demonstrates that a negative
correlation was found between these 2 parameters in eNOS
knockout mice (r=-0.80, P<0.01) but not in the
wild-type strain (r=+0.28, not significant). Thus the higher
the blood pressure level, the smaller the blood pressure variability
was. However, despite the higher blood pressure level, blood pressure
variance was significantly larger in eNOS knockout mice than in
controls, and only 2 out of 10 knockout mice had smaller blood pressure
variances (4.6 and 5.2 mm Hg2 ) than the average
blood pressure variance in the wild-type group (6.0
mm Hg2 ). This finding suggests that the chronically
elevated blood pressure level was not the cause of the increased blood
pressure variability in eNOS mutant animals.
|
Effects of eNOS Knockout on Blood Pressure Power Spectra
NO has been demonstrated to buffer blood pressure fluctuations at
frequencies between 0.1 and 0.5 s-1 (Hz) in
dogs7 and between 0.2 and 0.6 s-1
(Hz) in rats.8 In eNOS mutant mice, a marked increase in
spectral power of arterial blood pressure was observed
below 0.4 s-1 (Hz) compared with control mice
(Figure 1c and Table). Spectral power at frequencies
>0.4 s-1 (Hz) was comparable in both strains.
Therefore endothelium-derived NO can buffer blood
pressure fluctuations at frequencies <0.4 s-1
(Hz) in mice.
Effects of eNOS Knockout on Baroreceptor-Heart Rate Reflex
Sensitivity
Baroreceptorheart rate reflex sensitivity was calculated with
the sequence method. No significant difference was found between both
strains of mice (2.44±0.84 versus 2.69±0.81 ms/mm Hg; eNOS knockouts
versus wild-type controls; not significant). The number of sequences
per 1000 heartbeats was used as an index for baroreceptor reflex
activity. In eNOS knockout mice there were 3.1±0.9 sequences per 1000
heartbeats, whereas only 1.5±0.5 sequences were found in 1000
heartbeats in wild-type controls. This difference in the number of
sequences per 1000 heartbeats did not reach statistical significance
(P=0.15). A greater amount of sequences in the eNOS knockout
mice would suggest that the larger blood pressure variability in eNOS
knockout mice is partly compensated for by the baroreceptor reflex.
| Discussion |
|---|
|
|
|---|
Although we could demonstrate that NO generated by the
endothelial isoform of the NO synthase buffers
short-term blood pressure fluctuations, we were not able to rule out
that NO produced by other isoforms of the NO synthase also contribute
to this effect. For example, it has been demonstrated that long-term
treatment for 4 weeks with 7-nitro-indazole, a specific nNOS
antagonist, causes sustained hypertension in
rats.21 In this study, it was suggested that the
hypertensive effect of nNOS blockade is mediated by an increased
tubuloglomerular feedback sensitivity, which leads
to decreased glomerular filtration rate and an increased
body fluid volume. Similarly, selective neuronal NO synthase inhibition
has been shown to block furosemide-stimulated renin secretion in
vivo.22 Such renal mechanisms are unlikely to respond to
blood pressure fluctuations in the time range of 2 to 20 seconds, since
it has been shown that renal autoregulation reaches a maximum at
frequencies below 0.01 s-1 (Hz) (
>100
seconds) in conscious dogs.23 On the basis of these
findings, one would speculate that nNOS-generated NO does not
participate in the short-term blood pressurebuffering effects of NO.
On the other hand, it has been demonstrated in rabbits that nNOS
blockade can modulate baroreflex control of heart rate24
and that neuronal NO reduces sympathetic excitability in
pigs.25 These mechanisms, however, may be rapid enough to
respond to blood pressure fluctuations within seconds. Therefore an
additional blood pressurebuffering effect of NO derived from nNOS
cannot be completely ruled out.
Chronically increased blood pressure levels can cause increased blood pressure variability. Therefore the question arises whether the increased blood pressure variability in eNOS knockout mice is secondary to the hypertension observed in these mice. To address this question, we calculated the correlation between mean blood pressure and blood pressure variance and found a negative correlation between these 2 parameters in the eNOS knockout group (Figure 2). In addition, the increased blood pressure variability was not uniformly distributed over the entire frequency domain, as would have been expected if the enhanced blood pressure variability was secondary to hypertension. Instead, the increase in blood pressure variability was confined to a low frequency band between 0.05 and 0.4 s-1 (Hz). Thus the negative correlation between mean blood pressure and blood pressure variance together with the selective increase in low frequency spectral power suggests that in this particular model of hypertension, increased blood pressure variability does not rely on the chronically increased blood pressure level.
Marked fluctuations in blood pressure are hardly compatible with everyday life and can lead to end-organ damage.3 4 The best known and probably most effective mechanism to maintain arterial blood pressure within tight boundaries is the arterial baroreceptor reflex.5 6 The afferent component of this reflex consists of stretch receptors located in the carotid sinus region and the aortic arch, whereas the effector side of the reflex is mediated by the sympathetic and parasympathetic nervous system.26 However, the efferent portion of the reflex that depends on the integrity of the autonomic nervous system may not function properly in various pathophysiological conditions such as diabetic polyneuropathy,27 multiple sclerosis,28 or pure autonomic failure.29 Because nature in general provides organisms with compensatory systems that can step into the breach if critical organs are malfunctioning, it is not surprising that a second short-term blood pressurebuffering mechanism exists that is independent from the autonomic nervous system. Because blood pressure variability is larger in eNOS knockout mice than in wild-type controls and because it has been shown that an increase in vascular shear stress enhances aortic endothelial NO synthase expression in vivo,10 11 it is reasonable to assume that this second blood pressurebuffering mechanism is the local vascular NO system. It most likely operates by a shear stressinduced elevation in cytosolic Ca2+ content, which activates the endothelial isoform of NO synthase.9 12 13 The subsequently formed NO counterbalances the initial increase in arterial blood pressure and thereby maintains blood pressure at its initial level. It is remarkable that it has been demonstrated in conscious rats that the autonomic nervous system does not contribute to tonic NO-mediated vasodilatation.30 Thus this local vascular blood pressure buffer is largely independent from the autonomic nervous system, which may have particular importance in patients with autonomic dysfunctions.
Baroreceptor reflex sensitivity was found to be similar in eNOS mutant and wild-type control mice. Therefore the question arises as to why the baroreceptor reflex does not eliminate the enhanced blood pressure variability in eNOS knockout mice. Twice as many sequences in which blood pressure and interbeat interval simultaneously increased or decreased were found in the blood pressure time series obtained from eNOS knockout mice than in wild-type controls. This finding suggests that the higher blood pressure variability in eNOS knockout mice was partly compensated for by the baroreceptor reflex. However, activation of the baroreceptor reflex was not sufficient to completely suppress the enhanced blood pressure variability caused by the lack of a functional NO synthase within the endothelium. In addition, the higher activity of the baroreceptor reflex in eNOS knockout mice demonstrates that compensatory adaptation to the loss of the eNOS gene function occurred in these mice. Thus the actual effect of the endothelium-derived NO-dependent blood pressure buffer may have been underestimated in this study.
Taken together, endothelium-derived NO is crucial for the short-term regulation of arterial blood pressure. In addition, this system may partly compensate for malfunctions of the arterial baroreceptor reflex that are accompanied by a reduction in baroreceptor reflex sensitivity (as observed in diabetic autonomic neuropathy and other diseases) because it does not depend on the integrity of the autonomic nervous system. Hence endothelium-derived NO is critical for the maintenance of a constant blood pressure level, which is a prerequisite for organ hemodynamics and everyday life.
| Acknowledgments |
|---|
Received October 28, 1998; first decision November 30, 1998; accepted February 2, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. Desjardins, I. Lobysheva, M. Pelat, B. Gallez, O. Feron, C. Dessy, and J.-L. Balligand Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis Cardiovasc Res, August 1, 2008; 79(3): 527 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Patzak, A. Steege, E. Y. Lai, J. O. Brinkmann, E. Kupsch, N. Spielmann, A. Gericke, A. Skalweit, J. Stegbauer, P. B. Persson, et al. Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R429 - R437. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Desjardins, B. Sekkali, W. Verreth, M. Pelat, D. De Keyzer, A. Mertens, G. Smith, M.-C. Herregods, P. Holvoet, and J.-L. Balligand Rosuvastatin increases vascular endothelial PPAR{gamma} expression and corrects blood pressure variability in obese dyslipidaemic mice Eur. Heart J., January 1, 2008; 29(1): 128 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gericke, P. Martinka, I. Nazarenko, P. B. Persson, and A. Patzak Impact of {alpha}1-adrenoceptor expression on contractile properties of vascular smooth muscle cells Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1215 - R1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Parathath, I. Gravanis, and S. E. Tsirka Nitric Oxide Synthase Isoforms Undertake Unique Roles During Excitotoxicity Stroke, June 1, 2007; 38(6): 1938 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Baudrie, D. Laude, and J.-L. Elghozi Optimal frequency ranges for extracting information on cardiovascular autonomic control from the blood pressure and pulse interval spectrograms in mice Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R904 - R912. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Stauss Power spectral analysis in mice: what are the appropriate frequency bands? Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R902 - R903. [Full Text] [PDF] |
||||
![]() |
L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, D. Bell, L. R. Smith, L. Zhao, A. B. Devine, E. M. McHenry, D. P. Nicholls, and B. J. McDermott Differential Expression of Components of the Cardiomyocyte Adrenomedullin/Intermedin Receptor System following Blood Pressure Reduction in Nitric Oxide-Deficient Hypertension J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1269 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bell, Y.-Y. Zhao, E. J. Kelso, E. M. McHenry, L. M. Rush, V. M. Lamont, D. P. Nicholls, and B. J. McDermott Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H904 - H914. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Kurtz, K. A. Griffin, A. K. Bidani, R. L. Davisson, and J. E. Hall Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 2: Blood Pressure Measurement in Experimental Animals. A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): e22 - e33. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Martinka, J. Fielitz, A. Patzak, V. Regitz-Zagrosek, P. B. Persson, and H. M. Stauss Mechanisms of blood pressure variability-induced cardiac hypertrophy and dysfunction in mice with impaired baroreflex Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R767 - R776. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Kurtz, K. A. Griffin, A. K. Bidani, R. L. Davisson, and J. E. Hall Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 2: Blood Pressure Measurement in Experimental Animals: A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Hypertension, February 1, 2005; 45(2): 299 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Verreth, D. De Keyzer, M. Pelat, P. Verhamme, J. Ganame, J. K. Bielicki, A. Mertens, R. Quarck, N. Benhabiles, G. Marguerie, et al. Weight Loss-Associated Induction of Peroxisome Proliferator-Activated Receptor-{alpha} and Peroxisome Proliferator-Activated Receptor-{gamma} Correlate With Reduced Atherosclerosis and Improved Cardiovascular Function in Obese Insulin-Resistant Mice Circulation, November 16, 2004; 110(20): 3259 - 3269. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhang, T. E. Wilson, S. Witkowski, J. Cui, C. G. Crandall, and B. D. Levine Inhibition of nitric oxide synthase does not alter dynamic cerebral autoregulation in humans Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H863 - H869. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Hayashida, T. Takeuchi, T. Ozaki, H. Shimizu, K. Ando, A. Miyamoto, and E. Harada Bovine lactoferrin has a nitric oxide-dependent hypotensive effect in rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R359 - R365. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Perez de Lema, C. de Wit, C. D. Cohen, E. Nieto, A. Molina, B. Banas, B. Luckow, A. B. Vicente, F. Mampaso, and D. Schlondorff Angiotensin Inhibition Reduces Glomerular Damage and Renal Chemokine Expression in MRL/lpr Mice J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 275 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pelat, C. Dessy, P. Massion, J.-P. Desager, O. Feron, and J.-L. Balligand Rosuvastatin Decreases Caveolin-1 and Improves Nitric Oxide-Dependent Heart Rate and Blood Pressure Variability in Apolipoprotein E-/- Mice In Vivo Circulation, May 20, 2003; 107(19): 2480 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kramer and L. B. Kinter Evaluation and applications of radiotelemetry in small laboratory animals Physiol Genomics, May 13, 2003; 13(3): 197 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Cardiovascular and renal control in NOS-deficient mouse models Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R628 - R638. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-D. Wagner, V. Essmann, K. Mydlak, M. Wirth, G. Gmehling, J. Bohlender, H. M. Stauss, J. Gunther, I. Schimke, and H. Scholz Decreased susceptibility of cardiac function to hypoxia-reoxygenation in renin-angiotensinogen transgenic rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R153 - R160. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Malpas Neural influences on cardiovascular variability: possibilities and pitfalls Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H6 - H20. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. PATZAK, R. MROWKA, E. STORCH, B. HOCHER, and P. B. PERSSON Interaction of Angiotensin II and Nitric Oxide in Isolated Perfused Afferent Arterioles of Mice J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1122 - 1127. [Abstract] [Full Text] |
||||
![]() |
A. Just, J. Faulhaber, and H. Ehmke Autonomic cardiovascular control in conscious mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2214 - R2221. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rankinen, T. Rice, L. Perusse, Y. C. Chagnon, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard NOS3 Glu298Asp Genotype and Blood Pressure Response to Endurance Training : The HERITAGE Family Study Hypertension, November 1, 2000; 36(5): 885 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Stauss and P. B. Persson Role of Nitric Oxide in Buffering Short-Term Blood Press |